A single center study to examine neural correlates of cognition in subjects with mild Alzheimer's disease after three months of open label donepezil HCl [hydrochloride] (Aricept) treatment
Phase of Trial: Phase IV
Latest Information Update: 15 Jan 2010
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 03 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2008 The expected completion date for this trial is now 1 Aug 2008 as reported by ClinicalTrials.gov.
- 05 Oct 2007 Status changed from initiated to recruiting.